GH Archives - Page 10 of 10

1 minute read

FDA
News

uardant Health Announces New Data From Portfolio Of Blood Tests And GuardantINFORM Real-World Clinical-Genomic Platform At IASLC 2022 World Conference On Lung Cancer

August 5, 8:09 AM

Presentations to highlight role of liquid biopsy tests and real-world data in identifying resistance mechanisms to therapy, demonstrating impact of specific mutations on treatment efficacy, and informing therapeutic

1 minute read

Guardant Health Q2 EPS $(1.00) Beats $(1.21) Estimate, Sales $109.14M Beat $104.89M Estimate

By Benzinga Newsdesk

August 4, 7:00 PM

Guardant Health (NASDAQ:GH) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.21) by 17.36 percent. This is a 63.93 percent decrease over losses of $(0.61) per share from the

34 minute read

Earnings

Earnings Scheduled For August 4, 2022

By Benzinga Insights

August 4, 4:23 AM

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.

AAOI

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

July 12, 5:47 PM

Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.

ABVC

4 minute read

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

July 7, 1:55 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ABT

2 minute read

General

Guardant Health And Adicon Announce Partnership To Offer Genomic Profiling Tests To Accelerate Development Of New Cancer Therapies In China

By Bill Haddad

July 6, 6:15 AM

Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio of cancer tests to help advance drug development programs and their clinical trials SINGAPORE, July 6,

Feed Symbols: GH

uardant Health Announces New Data From Portfolio Of Blood Tests And GuardantINFORM Real-World Clinical-Genomic Platform At IASLC 2022 World Conference On Lung Cancer

Guardant Health Q2 EPS $(1.00) Beats $(1.21) Estimate, Sales $109.14M Beat $104.89M Estimate

Earnings Scheduled For August 4, 2022

12 Health Care Stocks Moving In Tuesday’s After-Market Session

10 Health Care Stocks Whale Activity In Today’s Session

Guardant Health And Adicon Announce Partnership To Offer Genomic Profiling Tests To Accelerate Development Of New Cancer Therapies In China